Karus Therapeutics Announces New Data from Phase I Cancer Trial at AACR
Oxfordshire, UK, 27 April 2020 – Karus Therapeutics Ltd (‘Karus’), a clinical-stage biopharmaceutical company developing precision medicines for cancer, announces that new data will be presented from its KA2507 Phase I study at the American Association for Cancer Research (AACR) Annual Meeting 2020. The Phase I clinical trial, conducted at The University of Texas MD […]